Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 12/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | GSK3A | P49840 | 1/20 | 0.40 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29673058 | 0.89 | TYMP (0.87) | TYMPALDH1A1LMNAALBMAPK1 | |
| SCHEMBL18486353 | 0.89 | TYMP (0.87) | TYMPALDH1A1LMNAALBMAPK1 | |
| SCHEMBL12614152 | 0.85 | TYMP (0.60) | TYMPALDH1A1LMNAALBMAPK1 | |
| SCHEMBL12541747 | 0.85 | TYMP (0.60) | TYMPALDH1A1LMNAALBMAPK1 | |
| SCHEMBL12540855 | 0.83 | TYMP (0.56) | TYMP | |
| SCHEMBL12541802 | 0.81 | TYMP (0.56) | TYMPALDH1A1LMNAALBMAPK1 | |
| SCHEMBL26757542 | 0.80 | TYMP (0.70) | TYMPALDH1A1LMNAALBMAPK1 | |
| SCHEMBL26757236 | 0.80 | TYMP (0.70) | TYMPALDH1A1LMNAALBMAPK1 | |
| SCHEMBL10394330 | 0.79 | TYMP (0.53) | TYMPALDH1A1LMNAALBMAPK1 | |
| SCHEMBL9773299 | 0.79 | TYMP (0.53) | TYMPPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5192749-A | Viricide, AIDS | SYNTEX (U.S.A.) INC. (US) | 1993-03-09 | — | — | US | disclosed |